• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

HYDERABAD: The shareholders of Suven Life Sciences Ltd (SLSL) at the AGM on Monday approved the enabling resolution to issue FCCBs, ADRs, GDRs, or other debt instruments or securities for an amount not exceeding $25 million.

In a release, the company said that the proceeds of global offering would be spent towards capital expenditure plans for manufacturing facilities, drug discovery and development support services facilities, and in-house drug discovery programmes. The AGM has authorised the SLSL board to workout various modalities to raise these funds, the release added.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Kothari Sugars settles dues to lenders

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line